Cart summary

You have no items in your shopping cart.

Avasimibe

SKU: orb1225989

Description

Avasimibe (CI-1011, PD-148515) is a potent, selective inhibitor of acyl-CoA: cholesterol O-acyl transferase (ACAT) with IC50 of 60 nM; potently reduces plasma cholesterol in chow-fed rats and in rabbits fed a cholesterol-free, casein-containing diet characterized by both hepatic overproduction of apo B-containing lipoproteins and delayed lipoprotein clearance; decreases both VLDL and LDL apolipoprotein B production in miniature pigs; synergistically reduces cholesteryl ester content in THP-1 macrophages combined with Atorvastatin,Dyslipidemia Phase 3 Discontinued.

Images & Validation

Key Properties

CAS Number166518-60-1
MW501.72102
Purity>98% (HPLC)
FormulaC29H43NO4S
SMILESc1(C(C)C)cc(cc(c1CC(NS(Oc1c(cccc1C(C)C)C(C)C)(=O)=O)=O)C(C)C)C(C)C
TargetACAT|CYP1A2|CYP2C19|CYP2C9
SolubilityDMSO: ≥ 28 mg/mL

Bioactivity

In Vivo
Animal model: SPF male mice (BALB/c-nude, 4 weeks old) bearing PCa cells. Dosage: 30 mg/kg. Administration: Intraperitoneally injected for 7 weeks. Result: Reduced tumour volume compared with that of the control group. Inhibited PCa growth and migration In vivo.
In Vitro
Cell Viability Assay Cell line: PCa cells (PC-3 and DU 145). Concentration: 0, 0.25, 5, 10, 20, 40 and 80 μM Incubation time: 1, 2, and 3 days. Result: Dose dependently inhibited PC-3 and DU 145 cell viability. Western blot analysis. Cell line: PCa cells (PC-3 and DU 145). Concentration: 10 and 20 μM. Incubation time: 48 hours. Result: Reduced protein levels of EMT-related proteins (β-catenin, Vimentin, N-cadherin, Snail, MMP9 and E-cadherin). Cell Cycle Analysis Cell line: PCa cells (PC-3 and DU 145). Concentration: 10 and 20 μM. Incubation time: 48 hours. Result: Induced G1 phase cycle arrest and altered the G1 phase-related protein levels in PCa cells.

Storage & Handling

StorageStorage temperature: -20°C. Stability: ≥ 2 years
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Alternative Names

CI-1011 | PD-148515 | CI1011 | PD148515 | CI 1011 | PD 148515

Similar Products

  • Avasimibe [orb1305068]

    99.16%

    166518-60-1

    501.72

    C29H43NO4S

    10 mg, 25 mg, 50 mg, 100 mg, 200 mg, 1 ml x 10 mM (in DMSO)
  • Avasimibe sodium [orb1739180]

    166518-61-2

    523.71

    C29H42NNaO4S

    50 mg, 100 mg, 25 mg
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Documents Download

Datasheet
Product Information
Download

Request a Document

Protocol Information

Avasimibe (orb1225989)

  • Star
  • Star
  • Star
  • Star
  • Star
  • 0.0
Based on 0 reviews

Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.

Login to Submit a Review

No reviews yet

Step 1: Enter information below

(Recommended: An additional animal making an allowance for loss during the experiment)

Step 2: Enter the in vivo formulation

(This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO +
%+
% Tween 80 +
%

Available Sizes

Select a size below

500 mg
10 mg
$ 80.00
25 mg
$ 130.00
50 mg
$ 200.00
100 mg
$ 340.00
200 mg
$ 530.00